Dr. Philippe Seiler

Philippe Seiler has broad experience in international and domestic private M&A transactions in various industries with a special focus on life science and health care transactions (incl. medtech, pharma, healthcare providers in various industries, suppliers to healthcare providers etc.). Philippe Seiler does not only cover big size transactions and takeovers but also focuses on small- and mid-size M&A transactions, private equity transactions as well as venture capital and startup transactions. Furthermore, he advises clients on regulatory matters relating to life science and health care law outside of M&A transactions.

Philippe Seiler is praised for his pragmatic and solution-oriented advice while at the same time having an excellent technical knowledge. Due to his extensive transaction experience he has a fast and good understanding of the business and the process. Philippe Seiler is ranked in Band 5 of the Corporate/M&A section by Chambers Global and Chambers Europe 2025 and recognized by Who is Who Legal in M&A and Governance. IFLR 1000 2024 ranks Philippe Seiler as Rising Star Partner and Euromoney’s Expert Guide lists Philippe Seiler as Rising Star in the fields of Corporate/M&A/Private Equity. He is further listed by Legal500 as a Leading individual and key contact for Commercial/M&A, Healthcare and Life Sciences as well as Transport and by Leaders League in Corporate/M&A.

Philippe Seiler graduated from the University of St. Gallen in 2008. From 2007 until 2009 he worked as a research and teaching assistant to Prof. Dr. Alfred Koller and in 2010 he became a trainee at Bär & Karrer. In 2011, Philippe Seiler obtained his PhD from the University of St. Gallen and he was admitted to the Zurich Bar in 2012.

Philippe Seiler has frequent speaking engagements on M&A-related topics and teaches regularly at a number of private and public Universities (e.g. LL.M. of the University of Zurich, Switzerland; Executive MBA University of St. Gallen).